Phase II study of FOLFIRI+Ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy (RAINCLOUD).RAINCLOUD-TR.
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2615323
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: FOLFIRI+Ramucirumab
(5-FU(bolus): 400mg/m2 on day1,
5-FU(ci): 2,400mg/m2 on day1-3 (46hr), l-LV: 200mg/m2 on day1,
CPT-11: 180mg/m2 on day1, Ramucirumab: 8mg/kg on day1) *Allow dose level -1 (150mg/m2)
RAINCLOUD-TR
Collecting blood 12mL at the time of before RAINCLOUD protocol treatment, and PD.
Primary outcome(s): Progression free survival
Study Design: single arm study, open(masking not used), no treatment control/standard of care control, parallel assignment, treatment purpose
创建时间：
2017-09-15
